Point-of-Care (POCT) Market Report: Trends, Forecast and Competitive Analysis to 2030

Point-of-Care (POCT) Market Report: Trends, Forecast and Competitive Analysis to 2030

Point-of-Care (POCT) Trends and Forecast

The future of the global point-of-care (POCT) market looks promising with opportunities in the hospital, diagnostic center, research laboratory, and home-care setting markets. The global point-of-care (POCT) market is expected to reach an estimated $70.0 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are augmenting demand for early diagnosis and treatment of diseases, expanding adoption of telehealth and remote healthcare delivery, and growing demand for affordable and user-friendly point of care testing devices.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Point-of-Care (POCT) by Segment

The study includes a forecast for the global point-of-care (POCT) by product type, technology, application, end use, and region.

Point-of-Care (POCT) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Glucose Monitoring
• Strips
• Meters
• Lancets
• Cardiometabolic Testing
• Cardiac Marker Testing
• Others

Point-of-Care (POCT) Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Lateral Flow Assays
• Dipsticks
• Microfluidics
• Molecular Diagnostics
• Immunoassays
• Agglutination Assays
• Flow-Through
• Solid Phase
• Biosensors

Point-of-Care (POCT) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cardio Metabolic Testing
• Infectious Disease Testing
• Nephrology Testing
• Drug-of-Abuse Testing
• Blood Glucose Testing
• Pregnancy Testing
• Cancer Biomarker Testing
• Others

Point-of-Care (POCT) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Research Laboratories
• Home-Care Settings
• Others

Point-of-Care (POCT) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Point-of-Care (POCT) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies point-of-care (POCT) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the point-of-care (POCT) companies profiled in this report include-

• Abbott
• F. Hoffmann-La Roche
• B.D.
• Siemens Healthcare
• Bio-Rad Laboratories
• Danaher
• Sekisui Diagnostics

Point-of-Care (POCT) Market Insights

Lucintel forecasts that blood glucose testing is expected to witness highest growth over the forecast period due to its features, such as convenience, easy to use, and can be performed at home or in a healthcare setting.

North America is expected to witness highest growth over the forecast period.

Features of the Global Point-of-Care (POCT) Market

Market Size Estimates: Point-of-care (POCT) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Point-of-care (POCT) market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Point-of-care (POCT) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the point-of-care (POCT) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the point-of-care (POCT) market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the point-of-care (POCT) market size?

Answer: The global point-of-care (POCT) market is expected to reach an estimated $70.0 billion by 2030.

Q.2 What is the growth forecast for point-of-care (POCT) market?

Answer: The global point-of-care (POCT) market is expected to grow with a CAGR of 10.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the point-of-care (POCT) market?

Answer: The major drivers for this market are augmenting demand for early diagnosis and treatment of diseases, expanding adoption of telehealth and remote healthcare delivery, and growing demand for affordable and user-friendly point of care testing devices.

Q4. What are the major segments for point-of-care (POCT) market?

Answer: The future of the point-of-care (POCT) market looks promising with opportunities in the hospital, diagnostic center, research laboratory, and home-care setting markets.

Q5. Who are the key point-of-care (POCT) market companies?

Answer: Some of the key point-of-care (POCT) companies are as follows:

• Abbott
• F. Hoffmann-La Roche
• B.D.
• Siemens Healthcare
• Bio-Rad Laboratories
• Danaher
• Sekisui Diagnostics

Q6. Which point-of-care (POCT) market segment will be the largest in future?

Answer: Lucintel forecasts that blood glucose testing is expected to witness highest growth over the forecast period due to its features, such as convenience, easy to use, and can be performed at home or in a healthcare setting.

Q7. In point-of-care (POCT) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the point-of-care (POCT) market by product type (glucose monitoring, strips, meters, lancets, cardiometabolic testing, cardiac marker testing, and others), technology (lateral flow assays, dipsticks, microfluidics, molecular diagnostics, immunoassays, agglutination assays, flow-through, solid phase, and biosensors), application (cardio metabolic testing, infectious disease testing, nephrology testing, drug-of-abuse testing, blood glucose testing, pregnancy testing, cancer biomarker testing, and others), end use (hospitals, diagnostic centers, research laboratories, home-care settings, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.